A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667
Clinical trial NCT04097938 · COMPLETED
Trial details
- NCT number
- NCT04097938
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-18
- Primary completion
- 2020-03-04
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.